A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients

Study of Talimogene Laherparepvec In Children With Advanced Non CNS Tumors

NCT02756845 ·Status: COMPLETED ·Phase: PHASE1

A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas

NCT00001564 ·Status: COMPLETED ·Phase: PHASE2

A Pilot Study of Autologous T-Cell Transplantation With Vaccine Driven Expansion of Anti-Tumor Effectors After Cytoreductive Therapy in Metastatic Pediatric Sarcomas

NCT00001566 ·Status: COMPLETED ·Phase: PHASE2

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma

NCT00923351 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Mobilization by Plerixafor of Haematopoietic Stem Cells in Children

NCT01225419 ·Status: COMPLETED ·Phase: PHASE2

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

NCT01288573 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

NCT01445379 ·Status: COMPLETED ·Phase: PHASE1

Panitumumab in Children With Solid Tumors

NCT00658658 ·Status: COMPLETED ·Phase: PHASE1

PK/PD of XM22 in Children With Ewing Family of Tumors or Rhabdomyosarcoma

NCT01585649 ·Status: COMPLETED ·Phase: PHASE1

Paclitaxel/Ifosfamide/Cisplatin Chemotherapy for High Risk Pediatric Germ Cell Tumor

NCT05455918 ·Status: RECRUITING ·Phase: PHASE2

Treatment of Pediatric Very High-risk Acute Lymphoblastic Leukemia in Korea

NCT06257394 ·Status: RECRUITING ·Phase: PHASE2

Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

NCT01944982 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Preliminary Efficacy of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) in Pediatric and Young Adult Participants With Solid Tumors

NCT02541604 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

NCT04478292 ·Status: RECRUITING ·Phase: PHASE3

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

NCT07148050 ·Status: RECRUITING ·Phase: PHASE1

Phase I Clinical Trial of Anlotinib in Progressive, Recurrent, and Refractory Sarcoma in Children

NCT04659733 ·Status: UNKNOWN ·Phase: PHASE1

A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue

NCT05634369 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

A Multiple Ascending Dose Study of R1507 in Children and Adolescents With Advanced Solid Tumors.

NCT00560144 ·Status: COMPLETED ·Phase: PHASE1

BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma

NCT00077493 ·Status: SUSPENDED ·Phase: PHASE1

Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors

NCT00607984 ·Status: UNKNOWN ·Phase: NA

Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)

NCT01431547 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB

NCT01125800 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor

NCT02933333 ·Status: UNKNOWN ·Phase: PHASE4

Pediatric Solid Tumor Metabolism [A Prospective Study Exploring Metabolism of Solid Tumors in Pediatrics]

NCT03686566 ·Status: COMPLETED

A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors

NCT05135975 ·Status: RECRUITING ·Phase: PHASE2